√ Increases blood supply
√ Modulates inflammation
√ Stimulates and regenerate tissue
√ Reduces acute and chronic pain
Advanced technology that heals
SoftWave therapy is typically a 10-minute treatment performed once a week for 6-8 weeks. SoftWave produces an unfocused shock wave which has the patented advantage of distributing maximum energy to a wide and deep area. This makes for reduced treatments and better outcomes.
Extra Corporeal Shock Wave Therapy (EWST)
Extra Corporeal Shock Wave Therapy (EWST) has been widely used to treat a wide range of conditions, including complex and chronic non-healing soft tissue wounds with different etiologies, such as DFUs, peripheral arterial diseases, venous leg ulcers, and pressure ulcers.
ESWT has been demonstrated to positively impact the four stages of wound healing:
- Inflammation: Low-energy shock waves can lower the pro-inflammatory response, induce the anti-inflammatory profile in macrophages, and alter the expression of cytokines and chemokines. Shock waves also reduce leukocyte and macrophage infiltration in isograft tissue and decrease the corresponding macrophage-derived inflammatory protein response.
- Infection: Shock waves have a bactericidal effect and can reduce the bacterial burden of the wound. They also increase the number of microvessels and improve the delivery of antibiotics to an infected wound.
- Apoptosis and necrosis: Shock wave treatment can decrease cellular apoptosis and reduce the necrosis of wounds.
- Remodeling and neovascularization: Shock wave treatment can accelerate granulation and re-epithelialization and reduce scar formation. It also increases overall blood circulation and stimulates cutaneous and muscular microcirculation.
- Extracorporeal shock wave therapy (ESWT) can effectively shorten the healing period and reduce the ineffectiveness of diabetic foot ulcer treatment by 4.8-fold.
- ESWT is not only superior to standard wound care, but also significantly better than hyperbaric oxygen therapy as an adjuvant treatment.